Clincosm LogoSign in Get a demo

cll

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

CLL, Leukemia Trial in Houston (Eltrombopag)

Completed
  • CLL
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 14, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Leukemia, CLL Trial in Houston (Lenalidomide)

Completed
Has Results
  • Leukemia
  • CLL
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 30, 2021

Leukemia, CLL, Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)

Completed
Has Results
  • Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 23, 2018

Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)

Unknown status
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Lenalidomide and Rituximab
  • La Jolla, California
  • +4 more
Sep 8, 2010

Chronic Lymphocytic Leukemia, CLL Trial in New Hyde Park, Houston, San Antonio (Oblimerson sodium, G3139)

Completed
  • Chronic Lymphocytic Leukemia
  • CLL
  • Oblimerson sodium, G3139
  • New Hyde Park, New York
  • +2 more
Nov 10, 2009